This expert consensus adapts the 2012 ESC STEMI guidelines to the Indian healthcare context, providing tailored recommendations for local physicians.
Answers are grounded in this paper and cite their sources.
Advocates India-specific ACS protocols for younger patients; challenges direct adoption of Western guidelines in STEMI-dominant populations.
Coronary artery disease (CAD) is a major contributor to morbidity and mortality in India, and its overall prevalence has risen dramatically over the past two decades. It has been seen that patients in India who suffer from Acute Coronary Syndrome (ACS) are younger (mean age, 56.3 years) and ST-elevation myocardial infarction (STEMI), constitute a higher proportion (60.6%) of ACS compared to non-ST elevation MI (NSTEMI). While these are erudite and exhaustive, they are tailored to the situation in developed countries. Although no evidence-based guidelines in India exists, an expert consensus on the management of STEMI provide some India specific recommendations. As there are differences between European and Indian settings regarding the availability of percutaneous coronary intervention (PCI) centers, initial delay in reperfusion, acceptability of concept of pre-hospital thrombolysis, 24 7 availability of trained staff, patient factors and financial challenges, the applicability of the recent ESC guidelines need to be critically looked at to adapt the recommendations in Indian setting. The objective of this expert consensus was to take the ESC 2012 STEMI guideline and tweak it with available Indian evidence by the help of a group of acclaimed Indian experts on the subject to provide a consensus document relevant for Indian STEMI patients which can provide a framework to guide Indian physicians and healthcare providers in making decisions for the optimal management of patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: